Abstract
Chapter 2 has described the pathoanatomy of coronary artery disease in humans and has discussed the pathophysiologic mechanisms that form the basis for many of the clinical manifestations of this disease. In the present chapter, the therapy of angina pectoris will be reviewed, including the chronic (stable), unstable, and variant types. Among the points of controversy that will be commented on in this chapter are the modification of risk factors and the role of exercise, clinical value of the calcium-antagonists compared to ß-adrenergic blocking agents, role of coronary angioplasty, prognosis of medically treated patients in the present era, selection of less disabled patients for coronary artery bypass surgery, reappearance of symptoms after surgical therapy, management of coronary artery disease associated with other disease states (both cardiac and noncardiac), and the role of medical and “prophylactic” coronary artery bypass surgery in patients with coronary artery disease who need to undergo noncardiac surgery.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Rosenman, R.H., Brand, R J., Scholtz, R.I., and Friedman, M. Multivariate prediction of coronary heart disease during 8.5 year follow-up in the Western Collaborative Group Study. Am. J. Cardiol. 37: 903, 1976.
Friedman, M., Thoresen, C.E., Gill, J J., Ulmer, D., Thompson, L., Powell, L., Price, V., Elek, S.R., Rabind, D.D., Breall, W.S., Piaget, G., Dixon, T., Bourg, E., Levy, R.A., and Tasto, D.L. Feasibility of altering type A behavior pattern after myocardial infarction. Recurrent coronary prevention project study: Methods, baseline results and preliminary findings. Circulation 66: 83, 1982.
Joy, M., Pollard, C.M., and Numan, T.O. Diurnal variation in exercise responses in angina pectoris. Br. Heart J. 48: 156, 1982.
Heaton, W.H., Marr, K.C., Capurro, N.L., Goldstein, R.E., and Epstein, S.E. Beneficial effect of physical training on blood flow to myocardium perfused by chronic collaterals in the exercising dog. Circulation 57: 575, 1978.
Schaper, W. Influence of physical exercise on coronary collateral blood flow in chronic experimental two-vessel occlusion. Circulation 65: 905, 1982.
Clausen, J.P. Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary artery disease. Prog. Cardiovasc. Dis. 18: 459, 1976.
Hagberg, J.M., Ehsani, A.A., and Holloszy, J.O. Effect of 12 months of intense exercise training on stroke volume in patients with coronary artery disease. Circulation 67: 1194, 1983.
Redwood, D.R., Rosing, D.R., and Epstein, S.E. Circulatory and symptomatic effects of physical training in patients with coronary artery disease and angina pectoris. N. Engl. J. Med. 286: 959, 1972.
Clausen, J.P. and Trap Jensen, J. Heart rate and arterial blood pressure during exercise in patients with angina pectoris: Effect of training and of nitroglycerin. Circulation 53: 436, 1976.
Fox, S.M., Naughton, J.P., and Gorman, P.A. Physical activity and cardiovascular health: The exercise prescription. Mod. Concepts Cardiovasc. Dis. 41: 21, 1972.
Amsterdam, E.A., Wilmore, J.H., and De-Maria, A.N. Exercise in Cardiovascular Health and Disease. New York: Yorke Medical Books, 1977, p. 313.
Kannel, W.B. Update on the role of cigarette smoking in coronary artery disease. Am. Heart J. 101: 319, 1981.
Folts, J.D. and Bonebrake, F.C. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: Inhibition with phentolamine. Circulation 65: 465, 1982.
Klein, L.W., Pichard A.D., Holt, J., Smith, H., Gorlin, R., and Teichholz, L.E. Effects of chronic tobacco smoking on the coronary circulation. J. Am, Coll. Cardiol. 1: 421, 1983.
Aronow, W.S. Smoking, carbon monoxide, and coronary heart disease. Circulation 48: 1169, 1973.
Aronow, W.S., Stemmer, E.A., Wood, B., Zweig, S., Tsao, K., and Raggio, L. Carbon monoxide and ventricular fibrillation threshold in dogs with acute myocardial injury. Am. Heart J. 95: 754, 1978.
Foster, J.R. Arrhythmogenic effects of carbon monoxide in experimental acute myocardial ischemia: Lack of slowed conduction and ventricular tachycardia. Am. Heart J. 102: 876, 1981.
Kaufman, D.W., Helmrich, S.P., Rosenberg, L., Miettinen, O.S., and Shapiro, S. Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N. Engl. J. Med. 308: 409, 1983.
Aronow, W.S. Effect of passive smoking on angina pectoris. N. Engl. J. Med. 299: 21, 1978.
Frolich, E.D. Newer concepts in antihypertensive drugs. Prog. Cardiovasc. Dis. 20: 385, 1978.
Stokes, G.S., Oates, H.F., and MacCarthy, E.P. Antihypertensive therapy: New pharmacological approaches. Am. Heart J. 100: 741, 1980.
Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: A cooperative study. JAMA 237: 255, 1977.
Kaplan, N.M. New choices for the initial drug therapy of hypertension. Am. J. Cardiol. 51: 1786, 1983.
Case, D.B., Atlas, S.A., Sullivan, and Laragh, J.H. Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril. Circulation 64: 765, 1981.
Kaplan, S.A., Lippe, B.M., Brinkman, C.R. III, Davidson, M.B., and Geffner, M.E. Diabetes mellitus. Am. Intern. Med. 96: 635, 1982.
Havel, RJ. Treatment of hyperlipidemias: Where do we start? Am. J Med. 73: 301, 1982.
St. Clair, R.W. Atherosclerosis regression in animal models: Current concepts of cellular and biochemical mechanisms. Prog. Cardiovasc. Dis. 26: 109, 1983.
Blankenhorn, D.H., Brooks, S.H., Selzer, R.H., and Barndt, T., Jr. The rate of atherosclerotic change during treatment of hyperlipoproteinemia. Circulation 57: 355, 1978.
Grundy, S.M., Bilheimer, D., Blackburn, H., Brown, W.V., Kwiterovich, P.O., Jr., Mattson, F., Schoenfeld, G., and Weidman, W.H. Rationale of the diet-heart statement of the American Heart Association: Report of Nutrition Committee. Circulation 65: 839A, 1982.
Brown, W.V., Goldberg, I.J. and Ginsberg H.N. Treatment of common lipoprotein disorders Prog. Cardiovasc. Dis. 27: 1, 1984.
Jones, P. and Gotto, A.M. Jr. Drug treatment of hyperlipidemia. Mod. Concepts Cardiovasc. Dis. 53: 53, 1984.
Brensike, J.F., Levy, R.I., Kelsey, S.F., Pass-amani, E.R., Richardson, J.M., Loh, I.K., Stone, NJ., Aldrich, R.F., Battaglini, J.W., Moriarty, DJ., Fisher, M.R., Friedman, L., Friedewald, W., Detre, K.M., and Epstein, S.E. Effects of therapy with cholestyramine on progression of coronary atherosclerosis: Results of NHLBI Type II Coronary Intervention Study. Circulation 69: 313, 1984.
Hartung, G.H., Squires, W.G., and Gotto, A.M., Jr. Effect of exercise training on plasma high-density lipoprotein cholesterol in coronary disease patients. Am. Heart J. 101: 181, 1981.
Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B., and Dawber, T.R. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. Ann. Intern. Med. 87: 393, 1977.
Brunton, T.L. On the use of nitrate of amyl in angina pectoris. Lancet 2: 97, 1867.
Cohn, P.F. and Gorlin, R. Physiologic and clinical actions of nitroglycerin. Med. Clin. North Am. 58: 407, 1974.
Mason, D.T. and Braunwald, E. The effects of nitroglycerin and amyl nitrate on arteriolar and venous tone in the human forearm. Circulation 32: 755, 1965.
Williams, J.F., Jr., Glick, G., and Braunwald, E. Studies on cardiac dimensions in intact unanesthetized man. V. Effects of nitroglycerin. Circulation 49: 146, 1974.
Burggraf, G.W. and Parker, J.O. Left ventricular volume changes after amyl nitrite and nitroglycerin in man as measured by ultrasound. Circulation 49: 146, 1974.
DeMaria, A.N., Vismara, L.A., Audtiore, K., Amsterdam, E.A., Zelis, R., and Mason, D.T. Effects of nitroglycerin on left ventricular cavity size and cardiac performance determined by ultrasound in man. Am. J. Med. 57: 754, 1974.
Feldman, R.L., Pepine, C.J., and Conti, C.R. Magnitude of dilatation of large and small coronary arteries by nitroglycerin. Circulation 64: 324, 1981.
Fuchs, R.M., Brinker, J.A., Guzman, P.A., Kross, D.E., and Yin, F.C.P. Regional coronary blood flow during relief of pacing-induced angina by nitroglycerin: Implications for mechanism of action. Am. J. Cardiol. 50: 19, 1982.
Slutsky, R., Battler, A., Gerber, K., Gordon, D., Froelicher, V., Karliner, J., and Ashburn, W. Effect of nitrates on left ventricular size and function during exercise: Comparison of sublingual nitroglycerin and nitroglycerin paste. Am. J. Cardiol. 45: 831, 1980.
Flessas, A.P. and Ryan, T J. Effects of nitroglycerin on isometric exercise. Am. Heart J. 105: 239, 1983.
Greenberg, H., Dwyer, E.M., Jr., Jameson, A.G., and Pinkernell, B.H. Effects of nitroglyc-erin on the major determinants of myocardial oxygen consumption. An angiographic and hemodynamic assessment. Am. J. Cardiol. 36: 426, 1975.
Lecerof, H. Influences of body position on exercise tolerance, heart rate, blood pressure and respiration rate in coronary insufficiency. Br. Heart J. 33: 78, 1971.
Christensson, B., Karlefors, T., and Westling, H. Hemodynamic effects of nitroglycerin in patients with coronary heart disease. Br. Heart J. 27: 511, 1965.
Thadani, U., Fung, H.L., Darke, A.C., and Parker, J.O. Oral isosorbide dinitrate in the treatment of angina pectoris: Dose-response relationship and duration of action during acute therapy. Circulation 62: 491, 1980.
Degre, S.G., Strappart, G.M., Sobolski, J.C., Berkenboom, G.M., Stoupel, E.E., and Vandermoten, P.P. Effect of oral sustained-released nitroglycerin on exercise capacity in angina pectoris: Dose-response relation and duration of action during double-blind crossover randomized acute therapy. Am. J. Cardiol. 51: 1595, 1983.
Chiong, M.A., West, R.O., and Parker, J.O. Influence of nitroglycerin on myocardial metabolism and hemodynamics during angina induced by atrial pacing. Circulation 45: 1044, 1972.
McAnulty, J.H., Hattenhauer, M.T., Rosch, J., Kloster, F.E., and Rahimtoola, S.H. Improvement in left ventricular wall motion following nitroglycerin. Circulation 51: 140, 1975.
McEwan, M.P., Berman, N.D., Morch, J.E., Feiglin, D.H., and McLaughlin, P.R. Effect of intravenous and intracoronary nitroglycerin on left ventricular wall motion and perfusion in patients with coronary artery disease. Am. J. Cardiol. 47: 102, 1981.
Salel, A.F., Berman, D.S., DeNardo, G.L., and Mason, D.T. Radionuclide assessment of nitroglycerin influence on abnormal left ventricular segmental contraction in patients with coronary artery disease. Circulation 53: 975, 1976.
Borer, J.S., Bacharach, S.L., Green, M.B., Kent, K.M., Johnston, G.S., and Epstein, S.E. Effect of nitroglycerin on exercise-induced abnormalities of left ventricular regional function and ejection in coronary artery disease. Assessment of radionuclide cineangiography in symptomatic and asymptomatic patients. Circulation 57: 314, 1978.
Bache, RJ., Ball, R.M., Cobb, F.R., Rembert, J.C., and Greenfield, J.C., Jr. Effects of nitroglycerin on transmural myocardial blood flow in the unanesthetized dog. J. Clin. Invest. 55: 1219, 1975.
Fam, W.M. and McGregor, M. Effect of coro nary vasodilator drugs on retrograde flow in areas of chronic myocardial ischemia. Circ. Res. 15: 355, 1964.
Macho, P. and Vatner, S.F. Effects of nitroglycerin and nitroprusside on large and small coronary vessels in conscious dogs. Circulation 64: 1101, 1981.
Weintraub, W.S., Akizuki, S., Agarwal, J.B., Bodenheimer, M.M., Banka, V.S., and Helfant, R.H. Comparative effects of nitroglycerin and nifedipine on myocardial blood flow and contraction during flow-limiting coronary stenosis in the dog. Am. J. Cardiol. 50: 281, 1982.
Cohen, M.V., Downey, J.M., Sonnenblick, E.H., and Kirk, E.S. The effects of nitroglycerin on coronary collaterals and myocardial contractility. J. Clin. Invest. 52: 2836, 1973.
McGregor, M. The nitrates and myocardial ischemia. Circulation 66: 689, 1982.
Cowan, C., Duran, P.V.M., Corsini, G., Goldschlager, N., and Bing, R.J. The effects of nitroglycerin on myocardial blood flow in man. Measured by coincidence counting and bolus injections of rubidium. Am. J. Cardiol. 24: 154, 1969.
Knoebel, S.B., McHenry, P.L., Bonner, AJ., and Phillips, J.F. Myocardial blood flow in coronary artery disease. Effect of right artrial pacing and nitroglycerin. Circulation 47: 690, 1973.
Ganz, W. and Marcus, H.S. Failure of intracoronary nitroglycerin to alleviate pacing-induced angina. Circulation 46: 880, 1972.
Goldstein, R.E., Stinson, E.B., Schere, J.L., Seningen, R.P., Grehl, T.M., and Epstein, S.E. Intraoperative coronary collateral function in patients with coronary occlusive disease. Nitroglycerin responsiveness and angiographic correlations. Circulation 49: 298, 1974.
Horwitz, L.D., Gorlin, R., Taylor, W J., and Kemp, H.G. Effects of nitroglycerin on regional myocardial blood flow in coronary artery disease. J. Clin. Invest. 50: 1578, 1971.
Maseri, A. Regional Myocardial Blood Flow in Man—Evaluation of Drugs. In Strauss, H.W., Pitt, B., and James, A.E. (eds.), Cardiovascular Nuclear Medicine. St. Louis: Mosby, 1974, p. 171.
Cohn, P.F., Maddox, D.E., Holman, B.L., Markis, J.E., Adams, D.F., and See, J.R. Effect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am. J. Cardiol. 39: 672, 1977.
Brown, B.G., Bolson, E., Petersen, R.B., Pierce, C.D., and Dodge, H.T. The mechanisms of nitroglycerin action: Stenosis vasodilatation as a major component of the drug response. Circulation 64: 1089, 1981.
Berkenboom, G.M., Sobolski, J.C., and Degre, S.G. Oral sustained-release nitroglycerin in chronic stable angina: A multicenter, double-blind, randomized crossover trial. Am. J. Cardiol. 53: 15, 1984.
Kaplan, K. Davison, R., Parker, M., Przybylek, J., Teagarden, J.R., and Lesch, M. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. Am. J. Cardiol. 51: 694, 1983.
Feldman, R.L., Marx, J.D., Pepine, CJ., and Conti, C.R. Analysis of coronary responses to various doses of intracoronary nitroglycerin. Circulation 66: 321, 1982.
Reichek, N., Goldstein, R.E., Redwood, D.R., and Epstein, S.E. Sustained effects of nitroglycerin ointment in patients with angina pectoris. Circulation 50: 348, 1974.
Parker, J.O., Augustine, R J., Burton, J.R., West, R.O., and Armstrong, P.W. Effect of nitroglycerin in ointment on the clinical and hemodynamic response to exercise. Am. J. Cardiol. 38: 162, 1976.
Parker, J.O. and Fung, H.-L. Transdermal nitroglycerin in angina pectoris. Am. J. Cardiol. 54: 471, 1984.
Abrams, J. New nitrate delivery systems: Buccal nitroglycerin. Am. Heart J. 105: 848, 1983.
Kimchi, A., Lee, G., Amsterdam, E., Fujii, K., Krieg, P., and Mason, D.T. Increased exercise tolerance after nitroglycerin oral spray: A new and effective therapeutic modality in angina pectoris. Circulation 67: 122, 1983.
Udhoji, V.N. and Heng, M.K. Hemodynamic effects of high-dose sustained-action oral isosorbide dinitrate in stable angina. Am. J. Med. 76: 234, 1984.
Markis, J.E., Gorlin, R., Mills, R.M., Williams, R.A., Schweitzer, P., and Ransil, B.J. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris. Am. J. Cardiol. 43: 265, 1979.
Lee, G., Mason, D.T., and DeMaria, A.N. Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Absence of nitrate cross-tolerance and self-tolerance shown by exercise testing. Am. J. Cardiol. 41: 82, 1978.
Dalai, JJ., Yao, L., and Parker, J.O. Nitrate tolerance: Influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin. J. Am. Coll. Cardiol. 2: 115, 1983.
Warren, S.G., Bremer, D.L., and Orgain, E.S. Long-term propranolol therapy for angina pectoris. Am. J. Cardiol. 37: 420, 1976.
Michaelson, S.P. and Wolfson, S. Role of propranolol in treatment of angina pectoris. Cardiovasc. Med. 3: 331, 1978.
Parker, J.O., West, R.O., and DiGiorgi, S. Hemodynamic effects of propranolol in coro-nary heart disease. Am. J. Cardiol. 21: 11, 1968.
Friedman, M J., Temkin, L.P., Goldman, S., and Ovitt, T.W. Effects of propranolol on resting and postextrasystolic potentiated left ventricular function in patients with coronary artery disease. Am. Heart J. 105: 81, 1983.
Marshall, R.C., Wisenberg, G., Schelbert, H.R., and Henze, E. Effect of oral propranolol on rest, exercise and postexercise left ventricular performance in normal subjects and patients with coronary artery disease. Circulation 63: 572, 1981.
Rainwater, J., Steele, P., Kirch, D., LeFree, M., Jensen, D., and Vogel, R. Effect of propranolol on myocardial perfusion images and exercise ejection fraction in men with coronary artery disease. Circulation 65: 77, 1982.
Hossack, R.F., Bruce, R.A., and Kusumi, F. Comprehensive analysis of exertional ECG changes before and after oral propranolol. Clin. Cardiol. 2: 270, 1979.
Armstrong, P.W., Chiong, M.A., and Parker, J.O. Effects of propranolol on the hemodynamic coronary sinus blood flow and myocardial metabolic response to atrial pacing. Am. J. Cardiol. 40: 83, 1977.
Mehta, J. and Mehta, P. Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease. Circulation 6: 1294, 1982.
Battock, DJ., Alvarez, H., and Chidsey, C.A. Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic activity in patients with angina pectoris. Circulation 39: 157, 1969.
Winniford, M.D., Huxley, R.L., and Hillis, L.D. Randomized, double-blind comparison of propranolol alone and a propranolol-verapamil combination in patients with severe angina of effort. J. Am. Coll. Cardiol. 1: 492, 1983.
Shand, D.G. Propranolol. N. Engl.]. Med. 293: 280, 1975.
Kern, M J., Ganz, P., Horowitz, J.D., Gaspar, J., Barry, W.H., Lorell, B.H., Grossman, W., and Mudge, G.H., Jr. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. Circulation 67: 1178, 1983.
Miller, R.R., Olson, H.G., Amsterdam, E.A., and Mason, D.T. Propranolol withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N. Engl. J. Med. 293: 416, 1975.
Goldstein, R.E., Corash, L.C., Tallman, J.F., Jr., Lake, C.R., Hyde, J., Smith, C.C., Capurro, N.L., and Anderson, J.C. Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects. Am. J. Cardiol. 47: 115, 1981.
Shiroff, R.A., Mathis, J., Zelis, R., Schneck, D.W., Babb, J.D., Leaman, D.M., and Hayes, A.H., Jr. Propranolol rebound-a retrospective study. Am. J. Cardiol. 41: 778, 1978.
Lindenfeld, J., Crawford, M.H., O’Rourke, R.A., Levine, S.P., Montiel, M.M., and Horwitz, L.D. Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris. Circulation 62: 704, 1980.
Rangno, R.E., Nattel, S., and Lutterodt, A. Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule. Am. J. Cardiol. 49: 828, 1982.
Pratt, C.M., Welton, D.E., Squires, W.G., Jr., Kirby, T.E., Hartung, G.H., and Miller, R.R. Demonstration of training effect during chronic ß-adrenergic blockade in patients with coronary artery disease. Circulation 64: 1125, 1981.
Morris, K.G., Higginbotham, M.B., Coleman, R.E., Shand, D.G., and Cobb, F.R. Comparison of high-dose and medium-dose propranolol in the relief of exercise-induced myocardial ischemia. Am. J. Cardiol. 52: 7, 1983.
Alderman, E.L., Davies, R.O., Crowley, J J., Lopes, M.G., Brooker, J.Z., Friedman, J.P., Graham, A.F., Matlof, H J., and Harrison, D.C. Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation 51: 964, 1975.
Thadani, U. and Parker, J.O. Propranolol in angina pectoris: Comparison of therapy given two and four times daily. Am. J. Cardiol. 46: 117, 1980.
Parker, J.O., Porter, A., and Parker, J.D. Propranolol in angina pectoris: Comparison of long-acting and standard-formulation propranolol. Circulation 65: 1351, 1982.
Frishman, W.H. Atenolol and timolol, two new systemic ß-adrenoceptor antagonists. N. Engl. J. Med. 36: 1456, 1982.
Brown, E J., Jr., Holman, B.L., Wynne, J., Swinford, R., and Cohn, P.F. Effect of timolol on exercise-induced reduction in regional ejection fraction in patients with coronary artery disease. Chest 84: 258, 1983.
McLeod, A.A. and Shand, D.G. Atenolol: A long-acting beta-adrenoceptor antagonist. Ann. Intern. Med. 96: 244, 1982.
DiBianco, R., Singh, S.N., Shah, P.M., Newton, G.C., Miller, R.R., Nahormek, P., Costello, R.B., Laddu, A.R., Gottdiener, J.S., and Fletcher, R.D. Comparison of the antianginal efficacy of acebutolol and propranolol: A multicenter, randomized, double-blind placebo-controlled study. Circulation 65: 1119, 1982.
Parker, J.O. Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris. Am. J. Cardiol. 51: 1062, 1983.
Taylor, S.H., Silke, B., and Lee, P.S. Intravenous beta-blockade in coronary heart disease: Is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful? N. Engl. J. Med. 306: 631, 1982.
Thadani, U., Davidson, C., Singleton, W., and Taylor, S.H. Comparison of five betaadrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris. Am. J. Med. 68: 243, 1980.
Braunwald, E. Mechanism of action of calciumchannel-blocking agents. N. Engl. J. Med. 307: 1618, 1982.
Maseri, A., Parodi, O., and Fox, K.M. Rational approach to the medical therapy of angina pectoris: The role of calcium antagonists. Prog. Cardiov. Dis. 25: 269, 1983.
Weiner, D.A. and Klein, M.D. Verapamil therapy for stable exertional angina pectoris. Am. J. Cardiol. 50: 1153, 1982.
Go, M., Jr. and Hollenberg, M. Improved efficacy of high-dose versus medium-and low-dose diltiazem therapy for chronic stable angina pectoris. Am. J. Cardiol. 53: 669, 1984.
Sherman, L.G. and Liang, C.S. Nifedipine in chronic stable angina: A double-blind placebo-controlled crossover trial. Am. J. Cardiol. 51: 706, 1983.
Bassan, M., Weiler-Ravell, D., and Shalev, O. The additive antianginal action of oral nifedipine in patients receiving propranolol. Circulation 66: 710, 1982.
Amman, K. and Ryden, L. Comparison of metoprolol and verapamil in the treatment of angina pectoris. Am. J. Cardiol, 49: 821, 1982.
DeMots, H., Rahimtoola, S.H., Kremkau, E.L., Bennett, W., and Mahler, D. Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. A hemodynamic, volumetric and metabolic study in patients without heart failure. J. Clin. Invest. 58: 312, 1976.
Crawford, M.H., LeWinter, M., O’Rourke, R.A., Karliner, J.S., and Ross, J.E., Jr. Combined propranolol and digoxin therapy in angina pectoris. Ann. Intern. Med. 83: 449, 1975.
Aspirin Myocardial Infarction Study Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 243: 661, 1980.
Hood, W.B., Jr. More on sulfinpyrazone after myocardial infarction (editorial). N. Engl. J. Med. 306: 988, 1982.
Frishman, W.H., Christodoulou, J., Webster, B., Smithen, C., Killip, T., and Scheidt, S. Aspirin therapy in angina pectoris: Effect on platelet aggregation exercise tolerance, and electrocar-diographic manifestations of ischemia. Am. Heart J. 92: 3, 1978.
Orlando, J., Aronow, W.S., Cassidy, J., and Prakash, R. Effect of ethanol on angina pectoris. Ann. Intern. Med. 84: 652, 1976.
Solignac, A., Ferguson, R J., and Bourassa, M.G. External counterpulsation: Coronary hemodynamics and use in treatment of patients with stable angina pectoris. Cath. Cardiolvasc. Diag. 3: 37, 1977.
Gruntzig, A. Transluminal dilatation of coronary artery stenoses. Lancet 1: 263, 1978.
Dorros, G., Cowley, MJ., Simpson, J., Bentivoglio, L.G., Block, P.C., Bourassa, M., Detre, K., Gosselin, AJ., Gruntzig, A.R., Kelsey, S.F., Kent, K.M., Mock, M.B., Mullin, S.M., Myler, R.K., Passamani, E.R., Stertzer, S.H., and Williams, D.O. Percutaneous transluminal coronary angioplasty: Report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation 67: 723, 1983.
Kent, K.M., Bentivoglio, L.G., Block, P.C., Cowley, MJ., Dorros, G., Gosselin, AJ., Gruntzig, A., Myler, R.K., Simpson, J., Stertzer, S.H., Williams, D.O., Fisher, L., Gillespie, M J., Detre, K., Kelsey, S., Mullin, S.M., and Mock, M.B. Percutaneous transluminal coronary angioplasty: Report from the Registry of the National Heart, Lung, and Blood Institute. Am. J. Cardiol. 49: 2011, 1982.
Kent, K.M., Bonow, R.O., Rosing, D.R., Ewels, CJ., Lipson, L.C., McIntosh, C.L., Bacharach, S., Green, M., and Epstein, S.E. Improved myocardial function during exercise after successful percutaneous transluminal coronary angioplasty. N. Engl. J. Med. 306: 441, 1982.
Scholl, J.M., Chaitman, B.R., David, P.R., Duprias, G., Brevers, G., Val, P.G., Lesperance, J., and Bourassa, M.G. Exercise electrocardiography and myocardial scintigraphy in the serial evaluation of the results of percutaneous transluminal coronary angioplasty. Circulation 66: 380, 1982.
Williams, D.O., Riley, R.S., Singh, A.K., and Most, A.S. Coronary circulatory dynamics before and after successful coronary angioplasty. J. Am. Coll. Cardiol. 1: 1268, 1983.
Lee, G., Ikeda, R., Herman, I., Dwyer, R.M., Bass, M., Hussein, H., Kozina, J., and Mason, D.T. The qualitative effects of laser irradiation on human arteriosclerotic disease. Am. Heart J. 105: 885, 1983.
Kannel, W.B. and Sorlie, P. Remission of clinical angina pectoris. The Framingham Study. Am. J. Cardiol. 42: 119, 1978.
Kannel, W.B. and Feinleib, M. Natural history of angina pectoris in the Framingham Study: Progress and survival. Am. J. Cardiol. 29: 154, 1972.
Frank, C.W., Weinblatt, E., and Shapiro, S. Angina pectoris in men: Prognostic significance or related medical factors. Circulation 47: 509, 1973.
White, P.D., Bland, E.F., and Miskall, E.W. Prognosis of angina pectoris: Long-term follow-up of 497 cases including note on 75 additional cases of angina pectoris decubitus. JAMA 123: 801, 1943.
Frank, C.W., Weinblatt, E., Shapiro, S., and Sager, R.V. Prognosis of men with coronary heart disease as related to blood pressure. Circulation 38: 432, 1968.
Heliovaara, M., Karvonen, MJ., Punsar, S., and Haapakoski, J. Importance of coronary risk factors in the presence or absence of myocardial ischemia. Am. J. Cardiol. 50: 1248, 1982.
Blackburn, H. The prognostic importance of the electrocardiogram after myocardial infarction: Experience in the coronary drug project. Ann. Intern. Med. 77:677, 197 2.
Kotler, M.N., Tabatznik, B., Mower, M.M., and Tominaga, S. Prognostic significance of ventricular ectopic beats with respect to sudden death in the late postinfarction period. Circulation 47: 959, 1973.
Kannel, W.B., Boyle, J.T., McNamara, P., Quickenton, P., and Gordon, T. Precursors of sudden coronary death. Circulation 51: 606, 1975.
Lown, B. and Wolf, M. Approach to sudden death from coronary heart disease. Circulation 44: 130, 1971.
Robb, G.P. and Seltzer, F. Appraisal of the double two-step exercise test. A long-term follow-up study of 3325 men. JAMA 234: 727, 1975.
Weiner, D.A., Ryan, TJ., McCabe, C.H., Chaitman, B.R., Sheffield, L.T., Ferguson, J.C., Fisher, L.D., and Tristani, F. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J. Am. Coll. Cardiol. 3: 772, 1984.
Reeves, T J., Oberman, A., Jones, W.B., and Sheffield, L.T. Natural history of angina pectoris. Am. J. Cardiol. 33: 423, 1974.
Bruschke, A.V., Proudfit, W.L., and Sones, F.M. Progress study of 490 consecutive nonsurgical cases of coronary diseases followed 5–9 years. I. Arteriographic correlations. Circulation 47: 1147, 1973.
Proudfit, W.L., Bruschke, A.V.G., and Sones, F.M., Jr. Natural history of obstructive coronary artery disease: Ten-year study of 601 nonsurgical cases. Prog. Cardiovasc. Dis. 22: 53, 1978.
Proudfit, W J., Bruschke, A.V.G., MacMillan, J.P., Williams, G.W., and Sones, F.M., Jr. Fifteen year survival study of patients with obstruc-tive coronary artery disease. Circulation 68: 986, 1983.
Murphy, M.L., Hultgren, N.H., Detre, K., Thomsen, J., and Takaro, T. Treatment of chronic stable angina. N. Engl. J. Med. 297: 621, 1977.
Mock, M.B., Ringqvist, I., Fisher, L.D., Davis, K.B., Chaitman, B.R., Kouchoukos, N.T., Kaiser, G.C., Alderman, E., Ryan, TJ., Russell, R.O.,Jr., Mullin, S., Fray, D., Killip, T., III, and Participants in the Coronary Artery Surgery Study. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 66: 562, 1982.
Harris, P J., Lee, K.L., Harrell, F.E., Jr., Behar, V.S., and Rosati, R.A. Outcome in medically treated coronary artery disease: Ischemic events. Nonfatal infarction and death. Circulation 62: 718, 1980.
Califf, R.M., Tomabechi, Y., Lee, K.L., Phillips, H., Pryor, D.B., Harrell, F.E., Jr., Harris, PJ., Peter, R.H., Behar, V.S., Kong, Y., and Rosati, R.A. Outcome in one-vessel coronary artery disease. Circulation 67: 283, 1983.
Lim, J.S., Proudfit, W.L., and Sones, F.M., Jr. Left main coronary arterial obstruction: Longterm follow-up of 141 nonsurgical cases. Am. J. Cardiol. 36: 131, 1975.
Conley, MJ., Ely, R.L., Kisslo, J., Lee, K.L., McNeer, J.F., and Rosati, R.A. The prognostic spectrum of left main stenosis. Circulation 57: 947, 1978.
Takaro, T., Peduzzi, P., Detre, K.M., Hultgren, H.N., Murphy, M.L., van der Bel-Kahn, J., Thomsen, J., and Meadows, W.R. Survival in subgroups of patients with left main coronary artery disease: Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation 66: 14, 1982.
Bruschke, A.V., Proudfit, E.L., and Sones, F.M. Progress study of 490 consecutive nonsurgical cases of coronary disease followed 5–9 tears. II. Ventriculographic and other correlations. Circulation 47: 1154, 1973.
Nelson, G.R., Cohn, P.F., and Gorlin, R. Prognosis in medically treated coronary artery disease. The value of the ejection fraction compared with other measurements. Circulation 52: 408, 1975.
Gross, H., Vaid, A.K., and Cohen, M.V. Prognosis in patients rejected for coronary revascularization surgery. Am. J. Med. 64: 9, 1978.
Hammermesiter, K.E., DeRouen, T.A., and Dodge, H.T. Variables predictive of survival in patients with coronary disease: Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 59: 421, 1979.
Cohn, P.F., Harris, P., Barry, W.H., Rosati, R.A., Rosenbaum, P., and Waternaux, C. Prognostic importance of anginal symptoms in angiographically defined coronary artery disease. Am. J. Cardiol. 47: 233, 1981.
Kent, K.M., Rosing, D.R., Ewels, CJ., Lipson, L., Bonow, R., and Epstein, S.E. Prognosis of asymptomatic or mildly symptomatic patients with coronary artery disease. Am. J. Cardiol. 49: 1823, 1982.
Moise, Al., Theroux, P., Taeymans, Y., Waters, D.D., Lesperance, J., Fines, P., Descoings, B., and Robert, P. Clinical and angiographic factors associated with progression of coronary artery disease. J. Am. Coll. Cardiol. 3: 659, 1984.
Marchandise, B., Bourassa, M.G., Chaitman, B.R., and Lesperance, J. Angiographic evaluation of the natural history of normal coronary arteries and mild coronary atherosclerosis. Am. J. Cardiol, 41: 216, 1978.
ß-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247: 1707, 1982.
The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Engl. J. Med. 304: 801, 1981.
Goldman, G.J. and Pichard, A.D. The natural history of coronary artery disease: Does medical therapy improve the prognosis? Prog. Cardiovasc, Dis. 25: 513, 1983.
Victor, M.F., Likoff, MJ., Mintz, G.S., and Likoff, W. Unstable angina pectoris of new onset: A prospective clinical and arteriographic study of 75 patients. Am. J. Cardiol. 47: 228, 1981.
Maseri, A. and Chierchia, S. Coronary artery spasm: Demonstration, definition, diagnosis, and consequences. Prog. Cardiovasc. Dis. 25: 169, 1982.
Chierchia, S., Brunelli, C., Simonetii, I., Lazzari, M., and Maseri, A. Sequence of events in angina at rest: Primary reduction in coronary flow. Circulation 61: 759, 1980.
Oliva, P.B. Unstable rest angina with ST-segment depression: Pathophysiologic considerations and therapeutic implications. Ann. Int. Med. 100: 424, 1984.
Johnson, S.M., Mauritson, D.R., Winniford, M.D., Willerson, J.T., Firth, B.G., Cary, J.R., and Hillis, L.D. Continuous electrocardiographic monitoring in patients with unstable angina pectoris: Identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. Am. Heart J. 103: 4, 1982.
Armstrong, P.W., Chiong, M.A., and Parker, J.O. The spectrum of unstable angina: Prognos-tic role of serum creatine kinase determination. Am. J. Cardiol. 49: 1849, 1982.
Boden, W.E., Bough, E.W., Benham, I., and Shulman, R.S. Unstable angina with episodic ST segment elevation and minimal creatine kinase release culminating in extensive, recurrent infarction. J Am. Coll. Cardiol. 2: 11, 1983.
Moses, J.W., Wertheimer, J.H., Bodenheimer, M.M., Banka, V.S., Feldman, M., and Helfant, R.H. Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease. Ann. Intern. Med. 94: 425, 1981.
Gerstenblith, G., Ouyang, P., Achuff, S.C., Bulkley, B.H., Becker, L.C., Mellits, E.D., Baughman, K.L., Weiss, J.L., Flaherty, J.T., Kallman, C.H., Llewellyn, M., and Weisfeldt, M.L. Nifedipine in unstable angina: A double-blind, randomized trial. N. Engl. J. Med. 306: 885, 1982.
Muller, J.E., Turi, Z.G., Pearle, D.L., Schneider, J.F., Serfas, D.H., Morrison, J., Stone, P.H., Rude, R.E., Rosner, B., Sobel, B.E., Tate, C., Scheiner, E., Robers, R., Hennekens, C.H., and Braunwald, E. Nifedipine and conventional therapy for unstable angina pectoris: A randomized, double-blind comparison. Circulation 69: 728, 1984.
Sobel, M., Salzman, E.W., Davies, G.C., Han-din, R.I., Sweeney, J., Ploetz, J., and Kurland, G. Circulating platelet products in unstable angina pectoris. Circulation 63: 300, 1981.
Folts, J.D., Gallagher, K., and Rowe, G.G. Blood flow reductions in stenosed canine coronary arteries: Vasospasm or platelet aggregation? Circulation 65: 248, 1982.
Lewis, H.D., Davis, J.W., Archibald, D.G., Steinke, W.E., Smitherman, T.C., Doherty, J.E., III, Schnaper, H.W., LeWinter, M.M., Linares, E., Pouget, J.M., Sabharwal, S.C., Chesler, E., and DeMots, H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: Results of a Veterans Administration Cooperative Study. N. Engl. J. Med. 309: 396, 1983.
Fuchs, R.M., Brin, K.P., Brinker, J.A., Guzman, P.A., Heuser, R.R., and Yin, F.C.P. Augmentation of regional coronary blood flow by intra-aortic balloon counterpulsation in patients with unstable angina. Circulation 68: 117, 1983.
Williams, D.O., Riley, R.S., Singh, A.K., Gewirth, H., and Most, A.S. Evaluation of the role of coronary angioplasty in patients with unstable angina pectoris. Am. Heart J. 102: 1, 1981.
Fulton, M., Lutz, W., Donald, K.W., Kirby, B J., Duncan, B., Morrison, S.L., Kerr, F., Julian, D.G., and Oliver, M.F. Natural history of unstable angina. Lancet 1: 860, 1972.
Krauss, K.R., Hutter, A.M., and DeSanctis, R.W. Acute coronary insufficiency: Course and follow-up. Circulation 45 (Suppl. I): 66, 1972.
Gazes, P.C., Mobley, E.M., Jr., Faris, H.M., Jr., Duncan, R.C., and Humphries, G.B. Preinfarctional (stable) angina-a prospective study; Ten year follow-up. Prognostic significance of electrocardiographic changes. Circulation 48: 331, 1973.
Unstable Angina Pectoris: National Cooperative Study Group to Compare Medical and Surgical Therapy. I. Report of protocol and patient population. Am. J. Cardiol. 37: 896, 1976.
Unstable Angina Pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy. II. In-hospital experience and initial follow-up results in patients with one, two and three vessel disease. Am. J. Cardiol. 42: 839, 1978.
Unstable Angina Pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy. III. Results in patients with S-T segment elevation during pain. Am. J. Cardiol. 45: 819, 1980.
Unstable Angina Pectoris: National Cooperative Study Group to Compare Medical and Surgical Therapy. IV. Results in patients with left anterior descending coronary artery disease. Am. J. Cardiol. 48: 517, 1981.
Araki, H., Koiwaya, Y., Nakagaki, O., and Nakamura, M. Diurnal distribution of ST-segment elevation and related arrhythmias in patients with variant angina: A study by ambulatory ECG monitoring. Circulation 67: 995, 1983.
Miller, D., Waters, D.D., Warnica, W., Szlachcic, J., Kreeft, J., and Theroux, P. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N. Engl. J. Med. 304: 763, 1981.
Pepine, CJ., Feldman, R.L., and Conti, C.R. Action of intracoronary nitroglycerin in refractory coronary artery spasm. Circulation 65: 411, 1982.
Antman, E., Muller, J., Goldberg, S., MacAlpin, R., Rubenfire, M., Tabatznik, B., Liang, C.S., Heupler, F., Achuff, S., Reichek, N., Geltman, E., Kerin, N.Z., Neff, R.K., and Braunwald, E. Nifedipine therapy for coronary-artery spasm: Experience in 127 patients. N. Engl. J. Med. 302: 1269, 1980.
Hill, J.A., Feldman, R.L., Conti, C.R., Hill, C.K., and Pepine, C.J. Long-term responses to nifedipine in patients with coronary spasm who have an initial favorable response. Am. J. Cardiol. 52: 24, 1983.
Schroeder, J.S., Lamb, I.H., Bristow, M.R., Ginsburg, R., Hung, J., and McAuley, B. Pre-vention of cardiovascular events in variant angina by long-term diltiazem therapy. J. Am. Coll. Cardiol. 1: 1507, 1983.
Freedman, S.B., Richmond, D.R., and Kelly, D.T. Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm. Am. J. Cardiol. 50: 711, 1982.
Winniford, M.D., Filipchuk, N., and Hillis, L.D. Alpha-adrenergic blockade for variant angina: A long-term, double-blind, randomized trial. Circulation 67: 1185, 1983.
Waters, D.D., Szlachcic, J., Miller, D., and The-roux, P. Clinical characteristics of patients with variant angina complicated by myocardial infarction or death within 1 month. Am. J. Car-dial. 49: 658, 1982.
Miller, D.D., Waters, D.D., Szlachcic, J., and Theroux, P. Clinical charcteristics associated with sudden death in patients with variant angina. Circulation 66: 588, 1982.
Cohn, P.F. Prognosis and treatment of asymptomatic coronary artery disease. J. Am. Coll. Cardiol. 1: 959, 1983.
McIntosh, H.D. and Garcia, J.A. The first decade of aortocoronary bypass grafting, 1967–1977. A review. Circulation 57: 405, 1978.
Vineberg, A. and Walker, J. The surgical treatment of coronary artery heart disease by internal mammary artery implantation: Report of 140 cases followed up to thirteen years. Dis. Chest 45: 190, 1964.
Favaloro, R. Direct and indirect coronary surgery. Circulation 41: 1197, 1972.
Effler, D.B. Myocardial revascularization surgery since 1945. Its evolution and impact. J. Thorac. Cardiovasc. Surg. 72: 823, 1976.
Sawyer, P.N., Kaplitt, MJ., Sobel, S., and DiMaio, D. Application of gas endarterectomy to atherosclerotic peripheral vessels and coronary arteries. Clinical and experimental results. Circulation 36 (Suppl. I): 163, 1967.
Favaloro, R.G. Saphenous vein graft in the surgical treatment of coronary artery disease: Operative technique. J. Thorac. Cardiovasc. Surg. 58: 178, 1969.
Johnson, W.D., Flemma, RJ., Lepley, D., Jr., and Ellison, E.H. Extended treatment of severe coronary artery disease: A total surgical approach. Ann. Surg. 170: 460, 1969.
Green, G.E. Internal mammary artery to coronary artery anastomosis: Three year experience with 165 patients. Ann. Thorac. Surg. 14: 260, 1972.
Cohn, P.F. Clinical, angiographic and hemodynamic factors influencing selection of patients for coronary artery bypass surgery. Prog. Cardiovas. Dis. 18:223, 1975
Report of Inter-Society Commission for Heart Disease Resources. Optimal resources for coronary artery surgery. Circulation 46: 325, 1972.
Alderman, E.L., Matlof, H J., Wexler, L., Shumway, N.E., and Harrison, D.C. Results of direct coronary artery surgery for the treatment of angina pectoris. N. Engl. J. Med. 388: 535, 1973.
Morris, G.C., Jr., Reul, GJ., Howell, J.F., Crawford, E.S., Chapment, D.W., Beazley, H.L., Winters, W.L., Peterson, P.K., and Lewis, J.M. Follow-up results of distal coronary artery bypass for ischemic heart disease. Am. J. Car-dial. 29: 180, 1972.
Lesperance, J., Bourassa, M.G., Biron, P., Campeau, L., and Saltiel, J. Aorta to coronary artery saphenous vein grafts. Preoperative angiographic criteria for successful surgery. Am. J. Cardiol. 30: 459, 1972.
Grondin, C.M., Lapage, G., Castonguay, Y.R., Meere, C., and Grondin, P. Aortocoronary bypass graft. Initial blood flow through the graft, and early postoperative patency. Circulation 44: 815, 1971.
Spencer, F.C., Green, G.E., Tice, D.A., Wallsh, E., Mills, N.L., and Glassman, E. Coronary artery bypass grafts for congestive heart failure. A report of experiences with 40 patients. J. Thorac. Cardiovasc. Surg. 62: 529, 1971.
Oldham, H.N., Jr., Kong, Y., Bartel, A.G., Morris, JJ., Jr., Behar, V.S., Peter, R.H., Rosati, R.A., Young, W.G., Jr., and Sabiston, D.C., Jr. Risk factors in coronary artery bypass surgery. Arch. Surg. 105: 918, 1972.
Cohn, P.F., Gorlin, R., Herman, M.V., Sonnenblick, E.H., Horn, H.R., Cohn, L.H., and Collins, J.J., Jr. Relation between contractile reserve and prognosis in patients with coronary artery disease and a depressed ejection fraction. Circulation 51: 414, 1975.
Kennedy, J.W., Kaiser, G.C., Fisher, L.D., Fritz, J.K., Myers, W., Mudd, J.G., and Ryan, TJ. Clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). Circulation 63: 793, 1981.
Helfant, R.H. Asynergy in coronary heart disease. Evolving clinical and pathophysiologic concepts. Ann. Intern. Med. 87: 475, 1977.
Cohn, L.H., Collins, J.J., Jr., and Cohn, P.F. Use of the augmented ejection fraction to select patients with severe left ventricular dysfunction for coronary revascularization. J. Thorac. Cardiovasc. Surg. 72: 835, 1976.
Nesto, R.W., Cohn, L.H., Collins, J.J., Jr., Wynne, J., Holman, L., and Cohn, P.F. Isotropic contractile reserve: A useful predictor of increased 5 year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am. J. Cardiol. 50: 39, 1982.
Kouchoukos, N.T., Oberman, A., Kirklin, J.W., Russeel, R.O., Jr., Karp, R.B., Pacifico, A.D., and Zorn, G.L. Coronary bypass surgery: Analysis of factors affecting hospital mortality. Circulation 62 (Suppl I): 84, 1980.
Chaitman, B.R., Alderman, E.L., Sheffield, L.T., Tong, T., Fisher, L., Mock, M.B., Weins, R.D., Kaiser, G.C., Roitman, D., Berger, R., Gersh, B., Schaff, H., Bourassa, M.G., Killip, T., and participating CASS medical centers. Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation 67: 302, 1982.
Raabe, D.S., Jr., Morise, A., Sbarbaro, J.A., and Gundel, W.D. Diagnostic criteria for acute myocardial infarction in patients undergoing coronary artery bypass surgery. Circulation 62: 869, 1980.
Aintablian, A., Hamby, R.I., Hoffman, I., Weisz, D., Voletti, C., and Wisoff, B.G. Significance of new Q waves after bypass grafting: Correlations between graft patency, ventriculogram, and surgical technique. Am. Heart J. 95: 429, 1978.
Gray, R J., Matloff, J.M., Conklin, C.M., Ganz, W., Charuzi, Y., Wolfstein, R., and Swan, HJ.C. Perioperative myocardial infarction: Late clinical course after coronary artery bypass surgery. Circulation 66: 1185, 1982.
Rahimtoola, S.H. Coronary bypass surgery for chronic angina-1981. A perspective. Circulation 65: 225, 1982.
Campeau, L., Lespérance, J. and Bourassa, M.G. Natural history of saphenous vein aortocoronary bypass grafts. Mod. Concepts Cardiovasc. Dis. 53: 59, 1984.
Palac, R.T., Meadows, W.R., Hwang, M.H., Loeb, H.S., Pifarre, R., and Gunnar, R.M. Risk factors related to progressive narrowing in aortocoronary vein grafts studied 1 and 5 years after surgery. Circulation 66 (Suppl I): 40, 1982.
Chesebro,J.H., Fuster, V., Elveback, L.R., Clements, I.P., Smith, H.C., Homles, D.R., Jr., Bardsley, W.T., Pluth, J.R., Wallace, R.B., Puga, F J., Orszulak, T.A., Piehler, J.M., Danielson, G.K., Schaff, H.V., and Frye, R.L. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N. Engl. J. Med. 310: 209, 1984.
Levine, J.A., Bechtel, DJ., Gorlin, R., Cohn, P.F., Herman, M.V., Cohn, L.H., and Collins, JJ., Jr. Coronary artery anatomy before and after direct revascularization surgery: Clinical and cinearteriographic studies in 67 selected patients. Am. Heart J. 89: 561, 1975.
Palac, R.T., Hwang, M.H., Meadows, W.R., Croke, R.P., Pifarre, R., Loeb, H.S., and Gun-nar, R.M. Progression of coronary artery disease in medically and surgically treated patients 5 years after randomization. Circulation 64 (Suppl II): 17, 1981.
Flaherty, J.T., Magee, P.A., Gardner, T.L., Potter, A., and MacAllister, N.P. Comparison of intravenous nitroglycerin and sodium nitroprusside for treatment of acute hypertension developing after coronary artery bypass surgery. Circulation 65: 1072, 1982.
Ribeiro, P., Sapsford, R., Evans, T., Parcharidis, G., and Oakley, C. Constrictive pericarditis as a complication of coronary artery bypass surgery. Br. Heart J. 51: 205, 1984.
Baddour, L.M. and Bisno, A.L. Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. Ann. Intern. Med. 97: 493, 1982.
Miller, D.W., Jr. and Bruce, R.A. Physiologic improvement following coronary artery bypass surgery. Circulation 57: 831, 1978.
Weiner, D.A., McCabe, C.H., Roth, R.L., Cutler, S.S., Berger, R.L., and Ryan, TJ. Serial exercise testing after coronary artery bypass surgery. Am. Heart J. 101: 149, 1981.
Sarma, R J. and Sanmarco, M.E. Reversal of exercise-induced hemodynamic and electrocardiographic abnormalities after coronary artery bypass surgery. Circulation 65: 684, 1982.
Wainwright, R J., Brennand-Roper, D.A., Maisey, M.N., and Sowton, E. Exercise thallium-201 myocardial scintigraphy in the follow-up of aortocoronary bypass graft surgery. Br. Heart J. 43: 56, 1980.
Block, T.A., Munag, J.A., and English, M.T. Improvement in exercise performance after unsuccessful myocardial revascularization. Am. J. Cardiol. 40: 673, 1977.
Johnson, W.D., Kayser, K.L., Pedraza, P.M., and Shore, R.T. Employment patterns in males before and after myocardial revascularization surgery: A study of 2229 consecutive male patients followed for as long as 10 years. Circulation 65: 1086, 1982.
Reduto, L.A., Lawrie, G.M., Reid, J.W., Whissenand, H.H., Noon, G.P., Kanon, D., DeBakey, M.E., and Miller, R.R. Sequential postoperative assessment of left ventricular performance with gated cardiac blood pool imaging following aortocoronary bypass surgery. Am. Heart J. 101: 59, 1981.
Lim, Y.L., Kalif, V., Kelly, M J., Mason, P J., Currie, P J., Harper, R.W., Anderson, S.T., Federman, J., Sterling, G.R., and Pitt, A. Radionuclide angiographic assessment of global and segmental left ventricular function at rest and during exercise after coronary artery bypass graft surgery. Circulation 66: 972, 1982.
Brundage, B.H., Massie, B.M., and Botvinick, E.H. Improved regional ventricular function after successful surgical revascularization. J. Am. Coll. Cardiol. 3: 902, 1984.
Rubenson, D.S., Tucker, C.R., London, E., Miller, D.C., Stinson, E.B., and Popp, R.L. Two-dimensional echocardiographic analysis of segmental left ventricular wall motion before and after coronary artery bypass surgery. Circulation 66: 1025, 1982.
Lawrie, G.M., Morris, G.C., Jr., Calhoon, J.H., Safi, H., Zamora, J.L., Beltengady, M., Baron, A., Silvers, A., and Chapman, D.W. Clinical results of coronary bypass in 500 patients at least 10 years after operation. Circulation 66 (Suppl I): 1, 1982.
Hammermeister, K.E. The effect of coronary bypass surgery on survival. Nog. Cardiovasc. Dis. 25: 297, 1983.
Loop, F.D., Golding, L.R., Macmillan, J.P., Cosgrove, D.M., Lyte, B.W., and Sheldon, W.C. Coronary artery surgery in women compared with men: Analysis of risks and long-term results. J. Am. Coll. Cardiol. 1: 383, 1983.
Oberman, A., Kouchoukos, N.T., Harrell, R.R., Holt, J.H., Jr., Russell, R.O., Jr., and Rackley, C.E. Surgical versus medical treatment in disease of the left main coronary artery. Lancet 2: 591, 1976.
Chaitman, B.R., Fisher, L.D., Burassa, M.G., Davis, K., Rogers, W.J., Maynard, C., Tyras, D.H., Berger, R.L., Judkins, M.P., Ringqvist, I., Mock, M.B., and Killip, T., and participating CASS medical centers. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am. J. Cardiol. 48: 765, 1981.
Peduzzi, P. and Hultgren, H.N. Effect of medical vs. surgical treatment on symptoms in stable angina pectoris. The Veterans Administration Cooperative Study of Surgery for coronary arterial occlusive disease. Circulation 60: 888, 1979.
Aranow, W.S. and Stemmer, E.A. Two-year follow-up of angina pectoris: Medical or surgical therapy. Ann. Intern. Med. 82: 208, 1975.
Mathur, V.S. and Guinn, G.A. Prospective randomized study of coronary bypass surgery in stable angina. The first 100 patients. Circulation 52(Suppl. I ): 33, 1975.
Kloster, F., Kremkau, L., Rahimtoola, S., Rosch, J., Ritzman, L., and Kanarek, P.H. Prospective randomized study of coronary bypass surgery for chronic stable angina. N. Engl. J. Med. 300: 149, 1979.
Fowles, R.E., Fitzgerald, J.W., Barry, W.H., and Hultgren, H.N. Long-term effects of coronary surgery versus medical therapy on exercise performance. Am. J. Cardiol. 41: 396, 1978.
Pantely, G.A., Kloster, F.E., and Morris, C.D. Late exercise test results from a prospective randomized study of bypass surgery for stable angina. Circulation 68: 413, 1983.
Takaro, T., Hultgren, H.N., Lipton, MJ., and Detre, K.M. The VA cooperative randomized study of surgery for coronary arterial occlusive disease. II. Subgroup with significant left main lesions. Circulation 54 (Suppl. 3): 116, 1976.
Detre, K., Peduzzi, P., Murphy, M., Hultgren, H., Thomsen, J., Oberman, A., Takaro, T., and the Veterans Administration Cooperative Study Group for Surgery for Coronary Arterial Occlusive Disease. Effect of bypass surgery on survival in patients in low-and high-risk subgroups delineated by the use of simple clinical variables. Circulation 63: 1329, 1981.
The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the veterans administration randomized trial of coronary bypass surgery for stable angina. New Engl. J. Med. 311: 1333, 1984.
European Coronary Surgery Study Group: Prospective randomized study of coronary artery bypass surgery in stable angina pectoris: A progress report on survival. Circulation 65 (Suppl. II): 67, 1982.
Whalen, R.E., Harrell, F.E., Jr., Lee, K.L., and Rosati, R.A. Survival of coronary artery disease patients with stable pain and normal left ventricular function treated medically or surgically at Duke University. Circulation 65 (Suppl. II): 49, 1982.
CASS principal investigators and their associates. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. N. Engl. J. Med. 310: 750, 1984.
Brown, C.A., Hutter, A.M., DeSanctis, R.W., Gold, H.K., Leinbach, R.C., Roberts-Niles, A., Austen, W.G., and Buckley, M.J. Prospective study of medical and urgent surgical therapy in randomizable patients with unstable angina pectoris: Results of in-hospital and chronic mortality and morbidity. Am. Heart J. 102: 959, 1981.
Rahimtoola, S.H. Coronary bypass surgery for unstable angina. Circulation 69: 841, 1984.
Hultgren, H.N., Shettigar, U.R., and Miller, D.C. Medical versus surgical treatment of unstable angina. Am. J Cardiol. 50: 663, 1982.
Rahimtoola, S.H., Ninley, D., Grunkemeier, G., Tepley, J., Lambert, L., and Starr, A. Ten-year survival after coronary bypass surgery for unstable angina. N. Engl. J. Med. 308: 676, 1983.
Sussman, E J., Goldberg, S., Poll, D.S., Macvaugh, H., III, Simson, M.B., Silber, S.A., and Kastor, J.A. Surgical therapy of variant angina associated with nonobstructive coronary disease. Ann. Intern. Med. 94: 771, 1981.
Betriu, A., Pomar, J.L., Bourassa, M.G., and Grondin, C.M. Influence of partial sympathetic denervation on the results of myocardial revascularization in variant angina. Am. J. Cardiol. 51: 661, 1983.
Waters, D.D., Bouchard, A., and Theroux, P. Spontaneous remission is a frequent outcome of variant angina. J. Am. Coll. Cardiol. 9: 195, 1983.
Bott-Silverman, C. and Heupler, F.A., Jr. Natural history of pure coronary artery spasm in patients treated medically. J Am. Coll. Cardiol. 2: 200, 1983.
Levine, S.A. and Kauvar, A J. Association of angina pectoris or coronary thrombosis with mitral stenosis. J. Mt. Sinai Hosp. 8: 754, 1942.
Befeler, B., Kamen, A.R., and MacLeod, M.B. Coronary artery disease and left ventricular function in mitral stenosis. Chest 57: 435, 1970.
Tadavarthy, S.M., Vlodaver, Z., and Edwards, J.E. Coronary atherosclerosis in subjects with mitral stenosis. Circulation 54: 519, 1976.
Basta, L.L., Raines, D., Najjar, S., and Kioschos, J.M. Clinical hemodynamic and coronary angiographic correlates of angina pectoris in patients with severe aortic valve disease. Br. Heart J. 37: 150, 1975.
Moraski, R.E., Russell, R.O., Jr., Mantle, J.A., and Rackley, C.E. Aortic stenosis, angina pectoris, coronary artery disease. Cath. Cardiovasc. Dis. 2: 157, 1976.
Graboys, T.B. and Cohn, P.F. The prevalence of angina pectoris and abnormal coronary arteriograms in severe aortic valcular disease. Am. Heart J. 93: 683, 1977.
Hakki, A.H., Kimbiris, D., Iskandrian, A.S., Segal, B.L., Mintz, G.S., and Bemis, C.E. Angina pectoris and coronary artery disease in patients with severe aortic valvular disease. Am. Heart J. 100: 441, 1980.
Bonchek, L.I., Anderson, R.P., and Rosch, J. Should coronary arteriography be performed routinely before valve replacement. Am. J. Cardiol. 31: 462, 1973.
Exadactylos, N., Sugrue, D.D., and Oakley, C.M. Prevalence of coronary artery disease in patients with isolated aortic valve stenosis. Br. Heart J 51: 121, 1984.
Lardani, H., Serrano, J.A., and Villamil, R J. Hemodynamics and coronary angiography in idiopathic hypertrophic subaortic stenosis. Am. J. Cardiol. 41: 476, 1978.
Scharf, S., Wexler, J., Longnecker, R.E., and Blaufox, M.D. Cardiovascular disease in patients on chronic hemodialytic therapy. Prog. Cardiovasc. Dis. 25: 343, 1980.
Weinrauch, L.A., D’Elia, J.A., Healy, R.W., Gleason, R.E., Takacs, F J., Libertino, J.A., and Leland, O.S. Asymptomatic coronary artery disease: Angiography in diabetic patients before renal transplantation. Relation of findings to postoperative survival. Ann. Intern. Med. 296: 1436, 1977.
Hillis, L.D. and Cohn, P.F. Noncardiac surgery in patients with coronary artery disease: Risks, precautions, and perioperative management. Arch. Intern. Med. 138: 972, 1978.
Wells, P.H. and Kaplan, J.A. Optimal management of patients with ischemic heart disease for noncardiac surgery by complementary anesthesiologist and cardiologist interaction. Am. Heart J. 102: 1029, 1981.
McCollum, C.H., Garcia-Rinaldi, R., Graham, J.M., and DeBakey, M.E. Myocardial revascularization prior to subsequent major surgery in patients with coronary artery disease. Surgery 81: 302, 1977.
Edwards, W.H., Mulherin, J.L., and Walker, W.E. Vascular reconstructive surgery following myocardial revascularization. Ann. Surg. 187: 653, 1978.
Barnes, R.W., Liebman, P.R., Marszalek, P.B., Kirk, C.L., and Goldman, M.H. The natural history of asymptomatic carotid disease in patients under going cardiovascular surgery. Surgery 90: 1075, 1981.
Chee, T.P., Prakash, N.S., Desser, K.B., and Benchimol, A. Postoperative supraventricular arrhythmias and the role of prophylactic digoxin in cardiac surgery. Am, Heart J. 104: 974, 1982.
Oka, Y., Frishman, W., Becker, R.M., Kadish, A., Strom, J., Matsumoto, M., Orkin, L., and Frater, R. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 10. Betaadrenoceptor blockade and coronary artery surgery. Am. Heart J. 99: 255, 1980.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Cohn, P.F. (1985). Therapy of Angina Pectoris. In: Cohn, P.F. (eds) Diagnosis and Therapy of Coronary Artery Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2569-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2569-7_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9613-3
Online ISBN: 978-1-4613-2569-7
eBook Packages: Springer Book Archive